Beverages - Brewers. Scored on the same transparent model behind the daily rankings.
★
BUD
Anheuser-Busch InBev SA/NV · Beverages - Brewers
53.5Score
$77.33Oct 9 close$152.3B
1Y Target$95.62Analyst consensus · 11 analysts
5Y Target$140.00Compound horizon
10Y Target$207.68Long-dated conviction
FCF$11.2bFY · 12/25A-
FCF $11.2b — top-quartile, exceptional for any sector · From the fiscal year ended 12/25 in SEC filings (OCF − CapEx) — this company files no quarterly cash-flow series, so a trailing-twelve-month figure can't be assembled.
Rev-0.7%FY YoYD+
Revenue -0.7% — shrinking; needs a catalyst to reverse · Latest fiscal year vs the prior one, from SEC filings — a trailing-twelve-month comparison couldn't be assembled from this company's filings.
D/E0.72B
D/E 0.72 — near the Consumer Defensive debt median (≈60th pctile)
P/E16.7xB+
P/E 16.7 — below the Consumer Defensive median (≈40th pctile)
PEG1.60C+
PEG 1.60 — modest premium; above fair value
Targets: 1-year is analyst consensus where covered, 5- and 10-year are model estimates; the DCF is a cross-check, not a target. Methodology
Quality-growth score · 53.5
Quality65.9
Growth40.7
Value57.0
Why this score
Raising its dividend
Entry · Margin of safety
52-week rangeNear 52-week high
11% off the 12-month high
vs DCF fair value26% belowest. fair value ~$105
What the price assumes: free cash flow shrinking about 3% next year, then recovering toward 4% a year by year ten — vs a starting rate of ~5% our model takes as the middle of three readings — analyst estimates, last year's revenue growth, and the company's own multi-year record.
Quality signals
Gross profitability15% · C+gross profit ÷ total assets — not in the score
ROIC7.1% · C+return on invested capital — leads the quality score
Model-generatedFrom reported fundamentals, checked against the figures above · Editorial standards
Why now
Beverages - Brewers · market cap $152.3b. 11% off the 52-week high of $86.60. 11 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $95.62 (implying +24% upside).
Moat
Net margin 14% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. FCF converts 132% of net income — earnings translate cleanly into cash. $152.3b market cap gives the company enough scale to absorb fixed costs that subscale competitors can't, without yet being so large that growth has to come from acquisition.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
Horizon
1-3 yr $95.62 (11-analyst consensus) — fundamentals + valuation re-rating. 5 yr $140.00 at ~13% CAGR — compounding case rests on the competitive position widening. 10 yr $207.68 if current growth sustains into durable earnings power.
BUD vs the Top Picks average
Pillar
BUD
Book avg
Diff
Quality
66
83
-17
Growth
41
89
-48
Value
57
76
-19
Average of today's Top 30 (mean score 82.6); size and sector limits also decide the book.
Score history · BUD
Trend
+0.2 over 82 daily scores
From 53.3 (Jun 22) → 53.5 (now)
One point per daily run; read From → To for the actual range.
BUD at a glance
Same audited fundamentals as the score, unless a card says otherwise.
Analyst estimate revisions
30-day change
-1.3%
90-day change
+0.1%
Forward EPS estimate
$4.91
Over the last 90 days, what analysts expect BUD to earn is essentially unchanged. The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.
Estimates move both ways and are not part of the Bull Rankings score. Biggest movers →
Position sizing · BUD
$
%
%
Shares to buy
25
Position size
$1,933
3.9% of portfolio
Stop price
$58.00
25% below $77.33
$ at risk if stopped
$483.31
budget $500.00 · 1% of portfolio
Math only: excludes commissions, slippage and gap risk. Inputs stay in your browser.
Anheuser-Busch InBev SA/NV (BUD) is a Beverages - Brewers company that scores 53.5 out of 100 on the Bull Rankings quality-growth model — a middling reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.
Its strongest graded signals are FCF (A-) and P/E (B+), while Rev (D+) rate weaker. On valuation, BUD sits about 26% below our discounted-cash-flow fair value (a margin of safety) — the current price implies free cash flow shrinking about 3% next year, then recovering toward 4% a year by year ten.
Is BUD a good stock to buy?
Bull Rankings scores BUD 53.5 out of 100 on its quality-growth model, which is a middling reading. That is driven by FCF (A-) and P/E (B+). A score is a quantitative screen of Anheuser-Busch InBev SA/NV's fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.
Why does BUD score 53.5 on Bull Rankings?
The score leans on quality at 65.9 out of 100, with growth the weakest pillar at 40.7 — the three combine geometrically, so a weak one cannot be papered over by a strong one. BUD earns its highest marks on FCF (A-) and P/E (B+), and is held back by Rev (D+). Each signal is graded against sector-aware thresholds rather than one absolute bar, so BUD is measured against Beverages - Brewers peers, not against the market as a whole.
Is BUD overvalued or undervalued?
Based on $77.33, BUD sits about 26% below our discounted-cash-flow fair value (a margin of safety) — the current price implies free cash flow shrinking about 3% next year, then recovering toward 4% a year by year ten. It trades at a 16.7x P/E (graded B+). Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.
What are the main risks of investing in BUD?
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.